Insider · CIK 0001810400
Annette Brookens Szady
director
Files at DGICA (DONEGAL GROUP INC). First filing Nov 14, 2025, latest Nov 14, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $89k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DGICA: DONEGAL GROUP INC
DGICAOct 9, 2026 · close 18.23
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | DONEGAL GROUP INC | $89k 4,500 shares | -64% | +45% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | DGICA DONEGAL GROUP INC | AGrant or award Class A Common Stock | +1,200 | $19.98 | $24k | 3,700 | Jan 2, 2026 |
| Nov 13, 2025 | DGICA DONEGAL GROUP INC | MOption exercise Class A Common Stock | +4,500 | $14.43 | $65k | 7,000 | Nov 14, 2025 |
| Nov 13, 2025 | DGICA DONEGAL GROUP INC | SOpen-market sale Class A Common Stock | -4,500 | $19.73 | $89k | 2,500 | Nov 14, 2025 |
| Nov 13, 2025 | DGICA DONEGAL GROUP INC | MOption exercise Optionsderivative | -4,500 | $14.43 | $65k | 0 | Nov 14, 2025 |
| Jan 2, 2025 | DGICA DONEGAL GROUP INC | AGrant or award Class A Common Stock | +500 | $15.47 | $7,735 | 2,500 | Jan 3, 2025 |
| Dec 19, 2024 | DGICA DONEGAL GROUP INC | AGrant or award Optionsderivative | +4,500 | $0.00 | $0 | 4,500 | Dec 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.